Anagliptin (SK-0403) is a highly potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with an IC50 of 3.8 nM. It is a research compound used to study mechanisms and therapeutic potential for type 2 diabetes in both in vitro enzymatic assays and in vivo animal models.